MSKCC Clinical Trial with Avastin for Endometrial Cancer
paris11
Member Posts: 159
A Three-Arm Randomized Phase II Study
of Paclitaxel/Carboplatin/ Bevacizumab
(NSC#704865, IND#7921), Paclitaxel/
Carboplatin/ Temsirolimus (NSC#683864,
IND#61010) and Ixabepilone
(NSC#710428,IND#59699)/Carboplatin/
Bevacizumab as Initial Therapy for Measurable
Stage III or IVA, Stage IVB, or Recurrent
Endometrial Cancer
212-639-2252
of Paclitaxel/Carboplatin/ Bevacizumab
(NSC#704865, IND#7921), Paclitaxel/
Carboplatin/ Temsirolimus (NSC#683864,
IND#61010) and Ixabepilone
(NSC#710428,IND#59699)/Carboplatin/
Bevacizumab as Initial Therapy for Measurable
Stage III or IVA, Stage IVB, or Recurrent
Endometrial Cancer
212-639-2252
0
Comments
-
Thanks for posting trial
Thanks for posting the trial. It is wonderful to see that there are some trials for endometrial cancer.0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 539 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards